News

This is a randomized multicentre phase II trial with a large translational component. The trial will evaluate the two standard chemotherapy regimens: modified folfirinox (mFFX) and gemcitabine/nab-paclitaxel (GA), in patients with untreated metastatic pancreatic ductal adenocarcinoma. Integrated into this phase II trial are a number of laboratory components including molecular profiling, patient derived organoid establishment, […]

A report compiled by the National Cancer Institute, the Centers for Disease Control and Prevention, the American Cancer Society, and the North American Association of Central Cancer Registries, Annual Report to the Nation on the Status of Cancer, has been released. The most recent data for this year’s report are from 2019; the findings are […]

Cancer deaths continue downward trend; modest improvements in survival for pancreatic cancer

Live-streamed webinar series created to introduce you to best-in-class experts from the field of pancreatic cancer research, technology, and science.

Our hearts are broken, our friend and NBA referee extraordinaire, Tony Brown, passed away this past Thursday from stage IV pancreatic cancer. The shock of his diagnosis only spurred Tony’s wife Tina to dig deep, summon her greatest, fiercest superpower, “protector-in-chief” to move heaven and earth to ensure Tony had the best treatment available. Tina […]

Cold Spring Harbor Laboratory (CSHL) Professor and Cancer Center Director David Tuveson was elected to the National Academy of Medicine (NAM) on October 17, 2022. He was recognized for his leadership in pancreatic cancer research.

Earlier this month, expert pancreatic cancer researchers and young investigators gathered in Boston for the AACR Special Conference on Pancreatic Cancer. With over 600 registered in-person attendees and over 230 abstracts submitted for presentation, it was an event full of ground-breaking research and researchers from all levels. The Conference was chaired by Andrew Lowy, MD, […]

Cristina R. Ferrone, MD, has been appointed chair of the department of surgery at Cedars-Sinai. Dr. Ferrone is a member of the Lustgarten Foundation’s Translational Advisory Group (TAG), a network of renowned experts working to identify the most innovative concepts and potential therapeutic approaches for all stages of pancreatic cancer and accelerating the testing of these […]